{"altmetric_id":3342841,"counts":{"readers":{"mendeley":10,"citeulike":1,"connotea":0},"total":{"posts_count":2},"wikipedia":{"unique_users_count":2,"unique_users":["en:2772013","en:4606394"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa4eb3cf058f61000284e","authors":["James E.J. Murphy","James J. Flynn","Dara M. Cannon","Patrick J. Guiry","Peter McCormack","Alan W. Baird","Gethin J. McBean","Alan K. Keenan"],"doi":"10.1016\/s0014-2999(02)01586-8","endpage":"67","first_seen_on":"2015-02-05T13:11:50+00:00","issns":["00142999"],"issue":"1-2","journal":"European Journal of Pharmacology","last_mentioned_on":1332445140,"links":["http:\/\/dx.doi.org\/10.1016\/S0014-2999(02)01586-8"],"pubdate":"2002-05-01T00:00:00+00:00","scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"61","title":"In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine","type":"article","volume":"444","mendeley_url":"http:\/\/www.mendeley.com\/research\/vitro-neuronal-vascular-responses-5hydroxytryptamine-modulation-4methylthioamphetamine-4methylthiome"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3627879,"mean":4.9457436126612,"rank":817440,"this_scored_higher_than_pct":63,"this_scored_higher_than":2287226,"rank_type":"exact","sample_size":3627879,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":93615,"mean":8.03669878437,"rank":24208,"this_scored_higher_than_pct":72,"this_scored_higher_than":68330,"rank_type":"exact","sample_size":93615,"percentile":72},"this_journal":{"total_number_of_other_articles":1684,"mean":2.3240772430184,"rank":111,"this_scored_higher_than_pct":40,"this_scored_higher_than":690,"rank_type":"exact","sample_size":1684,"percentile":40},"similar_age_this_journal_3m":{"total_number_of_other_articles":34,"mean":1.1621212121212,"rank":2,"this_scored_higher_than_pct":94,"this_scored_higher_than":32,"rank_type":"exact","sample_size":34,"percentile":94}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":4,"Student  > Postgraduate":1,"Student  > Master":2,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":3,"Chemistry":1,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"CL":1,"PT":1}}},"posts":{"wikipedia":[{"title":"4-Fluoroamphetamine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=483413875#altmetric_citation_7","license":"public","citation_ids":[3342841,3342843],"posted_on":"2012-03-22T19:39:00+00:00","summary":"4-Fluoroamphetamine (4-FA; 4-FMP; PAL-303; &quot;Flux&quot;), also known as para-fluoroamphetamine (PFA) is a psychoactive research chemical and designer drug of the phenethylamine and substituted amphetamine chemical classes.","page_url":"http:\/\/en.wikipedia.org\/?curid=2772013","wiki_lang":"en","author":{"name":"Testem","url":"http:\/\/en.wikipedia.org\/wiki\/User:Testem"}},{"title":"4-Methylthioamphetamine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=396764213#altmetric_citation_2","license":"public","citation_ids":[3342841,3342843],"posted_on":"2010-11-14T20:07:45+00:00","summary":"4-Methylthioamphetamine (4-MTA) is a designer drug developed in the 1990s by a team led by David E.","page_url":"http:\/\/en.wikipedia.org\/?curid=4606394","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}}]}}